Peri-operative β-blockade and haemodynamic optimisation in patients with coronary artery disease and decreasing exercise capacity presenting for major noncardiac surgery

Anaesthesia

Volumn 59, Issue 1, 2004, Pages 60-68

  Biccard, B M ^a  

^a UNIVERSITY OF KWAZULU NATAL   (South Africa)

Author keywords

Anaesthesia; Myocardial ischemia; Sympathetic nervous system; beta adrenergic blockade

Indexed keywords

BETA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; BETA 2 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARVEDILOL; DOBUTAMINE; ENOXIMONE; HEMOGLOBIN; METOPROLOL; OXYGEN; PHOSPHODIESTERASE INHIBITOR; PROPRANOLOL;

CARDIOPULMONARY INSUFFICIENCY; CARDIOVASCULAR RISK; CLINICAL TRIAL; CORONARY ARTERY DISEASE; DRUG EFFECT; DRUG POTENTIATION; EXERCISE; FUNCTIONAL ASSESSMENT; HEART FAILURE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART OUTPUT; HEART STROKE VOLUME; HEART VENTRICLE FAILURE; HEMODYNAMIC MONITORING; HIGH RISK PATIENT; HUMAN; LONG TERM CARE; LOW DRUG DOSE; MAJOR SURGERY; MORTALITY; OXYGEN CONSUMPTION; PERIOPERATIVE PERIOD; PROGNOSIS; REVIEW; SURGICAL RISK; SURGICAL TECHNIQUE;

ADRENERGIC BETA-ANTAGONISTS; CARDIAC OUTPUT; CORONARY ARTERIOSCLEROSIS; EXERCISE TOLERANCE; HEMODYNAMIC PROCESSES; HUMANS; PERIOPERATIVE CARE; SURGICAL PROCEDURES, OPERATIVE;

EID: 0346024255     PISSN: 00032409     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2044.2004.03455.x     Document Type: Review

References (69)

1. Juste RN, Lawson AD, Soni N. Minimising cardiac anaesthetic risk: The tortoise or the hare? Anaesthesia 1996; 51: 255-62.
2. Auerbach AD, Goldman L. β-Blockers and reduction of cardiac events in noncardiac surgery: Scientific review. Journal of the American Medical Association 2002; 287: 1435-44.
3. Mangano DT, Layug EL, Wallace A, Tateo I. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. New England Journal of Medicine 1996; 335: 1713-20.
4. Wallace A, Layug B, Tateo I et al. Prophylactic atenolol reduces postoperative myocardial ischemia. McSPI Research Group. Anesthesiology 1998; 88: 7-17.
5. Palda VA, Detsky AS. Perioperative assessment and management of risk from coronary artery disease. Annals of Internal Medicine 1997; 127: 313-28.
6. Boersma E, Poldermans D, Bax JJ et al. Predictors of cardiac events after major vascular surgery: Role of clinical characteristics, dobutamine echocardiography, and β-blocker therapy. Journal of the American Medical Association 2001; 285: 1865-73.
7. Urban MK, Markowitz SM, Gordon MA, Urquhart BL, Kligfield P. Postoperative prophylactic administration of β-adrenergic blockers in patients at risk for myocardial ischemia. Anesthesia and Analgesia 2000; 90: 1257-61.
8. Lee TH, Marcantonio ER, Mangione CM et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation 1999; 100: 1043-9.
9. Howell S, Sear J. Perioperative β-blockade. British Journal of Anaesthesia 2001; 87: 154-5.
10. Eagle KA, Berger PB, Calkins H et al. ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery - Executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to update the 1996 guidelines on perioperative cardiovascular evaluation for noncardiac surgery). Anesthesia and Analgesia 2002; 94: 1052-64.
11. Biccard BM. Perioperative β-adrenoceptor blockade in major non-cardiac surgery. South African Journal of Anaesthesia and Analgesia 2002; 8: 30-5.
12. Kern JW, Shoemaker WC. Meta-analysis of hemodynamic optimization in high-risk patients. Critical Care Medicine 2002; 30: 1686-92.
13. Mangano DT. Perioperative cardiac morbidity. Anesthesiology 1990; 72: 153-84.
14. Menard MT, Chew DK, Chan RK et al. Outcome in patients at high risk after open surgical repair of abdominal aortic aneurysm. Journal of Vascular Surgery 2003; 37: 285-92.
15. Clouse WD, Marone LK, Davison JK et al. Late aortic and graft-related events after thoracoabdominal aneurysm repair. Journal of Vascular Surgery 2003; 37: 254-61.
16. Elefteriades JA. Natural history of thoracic aortic aneurysms: Indications for surgery, and surgical versus nonsurgical risks. Annals of Thoracic Surgery 2002; 74: S1877-80.
17. Huynh TT, Miller CC 3rd, Estrera AL, Porat EE, Safi HJ. Thoracoabdominal and descending thoracic aortic aneurysm surgery in patients aged 79 years or older. Journal of Vascular Surgery 2002; 36: 469-75.
18. Sprung J, Abdelmalak B, Gottlieb A et al. Analysis of risk factors for myocardial infarction and cardiac mortality after major vascular surgery. Anesthesiology 2000; 93: 129-40.
19. Older P, Smith R, Courtney P, Hone R. Preoperative evaluation of cardiac failure and ischemia in elderly patients by cardiopulmonary exercise testing. Chest 1993; 104: 701-4.
20. Shammash JB, Trost JC, Gold JM et al. Perioperative β-blocker withdrawal and mortality in vascular surgery patients. American Heart Journal 2001; 141: 148-53.
21. Chassot PG, Delabays A, Spahn DR. Preoperative evaluation of patients with, or at risk of, coronary artery disease undergoing non-cardiac surgery. British Journal of Anaesthesia 2002; 89: 747-59.
22. Hlatky MA, Boineau RE, Higginbotham MB et al. A brief self-administered questionnaire to determine functional capacity (the Duke Activity Status Index). American Journal of Cardiology 1989; 64: 651-4.
23. Waxman K, Lazrove S, Shoemaker WC. Physiologic responses to operation in high risk surgical patients. Surgery, Gynecology and Obstetrics 1981; 152: 633-8.
24. Lugo G, Arizpe D, Dominguez G, Ramirez M, Tamariz O. Relationship between oxygen consumption and oxygen delivery during anesthesia in high-risk surgical patients. Critical Care Medicine 1993; 21: 64-9.
25. Davies CT, Thompson MW. Aerobic performance of female marathon and male ultramarathon athletes. European Journal of Applied Physiology and Occupational Physiology 1979; 41: 233-45.
26. Older P, Hall A, Hader R. Cardiopulmonary exercise testing as a screening test for perioperative management of major surgery in the elderly. Chest 1999; 116: 355-62.
27. Noakes TD. Maximal oxygen uptake: 'Classical' versus 'contemporary' viewpoints: A rebuttal. Medicine and Science in Sports and Exercise 1998; 30: 1381-98.
28. Dawood MM, Gupta DK, Southern J, Walia A, Atkinson JB, Eagle KA. Pathology of fatal myocardial infarction: Implications regarding pathophysiology and prevention. International Journal of Cardiology 1996; 57: 37-44.
29. Slogoff S, Keats AS. Does perioperative myocardial ischemia lead to postoperative myocardial infarction? Anesthesiology 1985; 62: 107-14.
30. Landesberg G, Luria MH, Cotev S et al. Importance of long-duration postoperative ST-segment depression in cardiac morbidity after vascular surgery. Lancet 1993; 341: 715-19.
31. Badner NH, Knill RL, Brown JE, Novik TV, Gelb AW. Myocardial infarction after noncardiac surgery. Anesthesiology 1998; 88: 572-8.
32. Poldermans D, Boersma E, Bax JJ et al. The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group. New England Journal of Medicine 1999; 341: 1789-94.
33. Boyd O. Perioperative cardiovascular optimization: Importance of relevance for anaesthesia. British Journal of Hospital Medicine 1997; 57: 219-23.
34. Astrand P-O, Cuddy TE, Saltin B, Stenberg J. Cardiac output during submaximal and maximal work. Journal of Applied Physiology 1964; 19: 268-74.
35. Fleg JL, O'Connor F, Gerstenblith G et al. Impact of age on the cardiovascular response to dynamic upright exercise in healthy men and women. Journal of Applied Physiology 1995; 78: 890-900.
36. Priebe H-J. The aged cardiovascular risk patient. British Journal of Anaesthesia 2000; 85: 763-8.
37. 2 uptake during submaximal exercise with β-adrenergic blockade at 4300 m. Journal of Applied Physiology 1998; 85: 1092-102.
38. Fleg JL, Schulman S, O'Connor F et al. Effects of acute β-adrenergic receptor blockade on age-associated changes in cardiovascular performance during dynamic exercise. Circulation 1994; 90: 2333-41.
39. Zaugg M, Schaub MC, Pasch T, Spahn DR. Modulation of β-adrenergic receptor subtype activities in perioperative medicine: Mechanisms and sites of action. British Journal of Anaesthesia 2002; 88: 101-23.
40. Metra M, Nodari S, D'Aloia A, Bontempi L, Boldi E, Die Cas L. A rationale for the use of β-blockers as standard treatment for heart failure. American Heart Journal 2000; 139: 511-21.
41. Gullestad L, Hallen J, Medbo JI, Gronnerod O, Holme I, Sejersted OM. The effect of acute vs chronic treatment with beta-adrenoceptor blockade on exercise performance, haemodynamic and metabolic parameters in healthy men and women. British Journal of Clinical Pharmacology 1996; 41: 57-67.
42. Yeager RA, Moneta GL, Edwards JM, Taylor LM Jr., McConnell DB, Porter JM. Reducing perioperative myocardial infarction following vascular surgery. The potential role of beta-blockade. Archives of Surgery 1995; 130: 869-73.
43. Stone JG, Foex P, Sear JW, Johnson LL, Khambatta HJ, Triner L. Myocardial ischemia in untreated hypertensive patients: Effect of a single dose of a beta-adrenergic blocking agent. Anesthesiology 1988; 68: 495-500.
44. Pasternack PF, Grossi EA, Baumann FG et al. Beta blockade to decrease silent myocardial ischemia during peripheral vascular surgery. American Journal of Surgery 1989; 158: 113-16.
45. Pasternack PF, Imparato AM, Baumann FG et al. The hemodynamics of beta-blockade in patients undergoing abdominal aortic aneurysm repair. Circulation 1987; 76 (3 Part 2): III 1-7.
46. Raby KE, Brull SJ, Timimi F et al. The effect of heart rate control on myocardial ischemia among high-risk patients after vascular surgery. Anesthesia and Analgesia 1999; 88: 477-82.
47. Bostrom P, Balldin M, Lilja B, Johansson B. The effect of atenolol on the left ventricular performance in patients with angina pectoris measured with isotope technique. Acta Medica Scandinavica 1988; 223: 239-45.
48. Marshall RC, Wisenberg G, Schelbert HR, Henze E. Effect of oral propranolol on rest, exercise and postexercise left ventricular performance in normal subjects and patients with coronary artery disease. Circulation 1981; 63: 572-83.
49. Bech J, Madsen JK, Kelbaek H, Hvid-Jacobsen K, Skagen K. Metoprolol abolishes exercise-induced left ventricular dysfunction in patients with silent ischemia. American Journal of Cardiology 1996; 78: 871-5.
50. Shub C. Heart failure and abnormal ventricular function. Pathophysiology and clinical correlation (Part 2). Chest 1989; 96: 906-14.
51. Sakate Y, Yoshiyama M, Hirata K et al. Relationship between Doppler-derived left ventricular diastolic function and exercise capacity in patients with myocardial infarction. Japanese Circulation Journal 2001; 65: 627-31.
52. Yuasa F, Sumimoto T, Takeuchi M et al. Effects of left ventricular diastolic dysfunction on exercise capacity three to six weeks after acute myocardial infarction in men. American Journal of Cardiology 1995; 75: 14-17.
53. Schulman SP, Lakatta EG, Fleg JL, Lakatta L, Becker LC, Ggerstenblith G. Age-related decline in left ventricular filling at rest and exercise. American Journal of Physiology 1992; 32: H1932-8.
54. Gudjonsson T, Rakho PS. Relation of 'inotropic reserve' to functional capacity in heart failure secondary to ischemic or nonischemic cardiomyopathy. American Journal of Cardiology 2002; 89: 1057-61.
55. Waagenstein F, Caidahl K, Wallentin I, Bergh C-H, Hjalmarson A. Long-term β-blockade in dilated cardiomyopathy. Effects of short- and long-term metoprolol treatment followed by withdrawal and readministration of metoprolol. Circulation 1989; 80: 551-63.
56. Packer M, Fowler MB, Roecker EB et al. for the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) Study Group. Effect of carvedilol on the morbidity of patients with severe chronic heart failure: Results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study. Circulation 2002; 106: 2194-9.
57. Sear JW, Foex P, Howell SJ. Effect of chronic intercurrent medications with β-adrenoceptor blockade or calcium channel entry blockade on postoperative silent myocardial ischaemia. British Journal of Anaesthesia 2000; 84: 311-15.
58. Howell SJ, Sear YM, Yeates D, Goldacre M, Sear JW, Foex P. β-Blockers and perioperative cardiovascular risk. British Journal of Anaesthesia 1999; 82: 458.
59. Sear JW, George S, Sear YM, Foex P. Can we predict the development of postoperative cardiovascular complications in non-cardiac surgical patients? British Journal of Anaesthesia 1999; 82 (Suppl. 1): 4.
60. Higham HE, Sear JW, Sear YM, Neill F, Foex P. Does perioperative silent myocardial ischaemia predict long-term adverse outcome in surgical patients. British Journal of Anaesthesia 2000; 85: 651-2p.
61. Ten Broecke PWC, De Hert SG, Mertens E, Adriaensen HF. Effect of preoperative β-blockade on perioperative mortality in coronary surgery. British Journal of Anaesthesia 2003; 90: 27-31.
62. Cleland JGF, McGowan J, Clark A, Freemantle N. The evidence for β blockers in heart failure. British Medical Journal 1999; 318: 824-5.
63. Garg RK, Sorrentino MJ. Beta blockers for CHF. Adrenergic blockade dramatically reduces morbidity and mortality. Postgraduate Medicine 2001; 109: 49-56.
64. Krum H, Roecker EB, Mohacsi P et al. for the Carvedilol Prospective Randomized Cumulative Survival Study Group. Effects of initiating carvedilol in patients with severe chronic heart failure: Results from the COPERNICUS Study. Journal of the American Medical Association 2003; 289: 712-18.
65. Lechat P, Escolano S, Golmrad JL et al. on behalf of the CIBIS Investigators. Prognostic value of bisoprolol-induced hemodynamic effects in heart failure during the Cardiac Insufficiency Bisoprolol Study (CIBIS). Circulation 1997; 96: 2197-205.
66. Everaert H, Vanhove C, Franken PR. Effect of beta-blockade on low-dose dobutamine-induced changes in left ventricular function in healthy volunteers: Assessment by gated SPET myocardial perfusion scintigraphy. European Journal of Nuclear Medicine 2000; 27: 419-24.
67. Perlini S, Meyer TE, Foex P. Effects of preload, afterload and inotropy on dynamics of ischemic segmental wall motion. Journal of the American College of Cardiology 1997; 29: 846-55.
68. Metra M, Nodari S, D'Aloia A et al. Beta-blocker therapy influences the hemodynamic response to inotropic agents in patients with heart failure: A randomized comparison of dobutamine and enoxamine before and after chronic treatment with metoprolol or carvedilol. Journal of the American College of Cardiology 2002; 40: 1248-58.
69. Sinclair S, James S, Singer M. Intraoperative intravascular volume optimisation and length of hospital stay after repair of proximal femoral fracture: Randomised controlled trial. British Medical Journal 1997; 315: 909-12.